Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Advancing Clinical Trial Design in Regulatory Science and Policy

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
Chair
Lillian L. Siu
Princess Margaret Cancer Centre, Toronto, ON, Canada
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Adaptively randomized seamless-phase multiarm platform trial: Glioblastoma Multiforme Adaptive Global Innovative Learning Environment (GBM AGILE)
Donald A. Berry
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Under-reporting of research biopsies in clinical trials in oncology
Christine M Parseghian
U.T. MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
How many tumor indications should be initially studied in clinical development of next-generation immunotherapies?
Cong Chen
Merck & Co., Inc., Collegeville, PA, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Experiences and lessons from innovative dose escalation designs in early-phase oncology
Jiawen Zhu
F. Hoffmann-La Roche Ltd, New York, NY, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5